A survey by MJH Life Science reveals how patient communication has evolved across clinical practices in the wake of COVID-19.
According to a survey by MJH Life Sciences™, physicians across multiple specialties have had increased communication with patients since the onset of coronavirus disease 2019 (COVID-19), mostly focused on acute, chronic, and COVID-19–related issues. Increased communication between physicians and patients is in large part due to patient apprehension about receiving health services in person as well as the need for practitioners to inform their patients that services are still available.
Based on the survey, reasons for utilizing telehealth in the future include flexibility, safety of staff and patients, adaptability, communication, and compassion. The big-gest concern for many physicians regarding reopening facilities was the ability to create a safe environment for patients and staff.
Physicians surveyed included practicing oncologists, inter-nal medicine and family/general practice, neurology, pediat-rics, obstetrician/gynecology, dermatology, ophthalmology, psychiatry, and rheumatology. In total, 1324 responses were received, with 43 responses from oncology specialists and 243 responses from primary care physicians.
Almost 90% of primary care physicians who participated in the survey inform their patients about COVID-19 testing opportunities. Respons-es showed that more than half of these physicians (54%) will continue using telehealth and other remote services more often to communicate with their patients, even when the pandemic is over. A challenge for this space is providing care for patients who lack access to technology and may find it more difficult to take advantage of telehealth services, according to 23% of primary care physicians surveyed.
Oncology specialists reported that surgical procedures were a priority once in-person vis-its resume, followed closely by medical visits. They also noted that they will continue to use telemedicine for screening and communication even after practices reopen.
Overcoming Barriers in Cancer Clinical Trials: A Path Forward for Better Patient Care
April 29th 2024Clinical trials play a pivotal role in developing effective therapies, yet their integration is challenged by issues such as insufficient reimbursement structures, misaligned incentives, physician burnout, and a complex regulatory environment.
Read More
Gholam Analyzes Treatment Outcomes for Advanced HCC in Child-Pugh B Population
April 28th 2024During a live Community Case Forum event in partnership with the Tennessee Oncology Practice Society, Pierre Gholam, MD, examined the current state of treatment for patients with hepatocellular carcinoma, looking in particular at what data is available for those with Child-Pugh B and C status who have poorer outcomes and have limited data from prospective clinical trials.
Read More